Status:

COMPLETED

A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

Lead Sponsor:

University of Rochester

Conditions:

Urinary Incontinence

Eligibility:

FEMALE

21-90 years

Phase:

NA

Brief Summary

The purpose of the study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.

Detailed Description

A multi-center clinical trial of Botulinum-A Toxin (Botox) for refractory urge incontinence.

Eligibility Criteria

Inclusion

  • Female subjects 21-90 years of age
  • subjects has urinary incontinence on 3 day bladder diary
  • subject has severe incontinence
  • urine dipstick or urine culture negative for urinary tract infection
  • cystometrogram without stress urinary leakage
  • must have failed at least one anti-cholinergic medication
  • negative urine pregnancy test on day of administration of study medication

Exclusion

  • history of carcinoma of the bladder
  • presence of foreign body in the bladder, cystitis or other correctable etiology for Urge Urinary Incontinance
  • gross fecal incontinence
  • known allergy to sulfa or ciprofloxacin or to lidocaine
  • any medical condition that may put the subject at increased risk with exposure to Botox
  • females who are pregnant, breast-feeding, or planning a pregnancy during the study or who are of child-bearing potential
  • known allergy to any of the components in the study medication
  • prior documented resistance to Botox
  • evidence of recent alcohol or drug abuse
  • concurrent participation in another investigational drug or device study within 30 days

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT00345332

Start Date

October 1 2005

End Date

May 1 2011

Last Update

July 11 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University of California at Davis

Sacramento, California, United States, 95817

2

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

3

Duke University Medical Center

Durham, North Carolina, United States, 27710